GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nxera Pharma Co Ltd (OTCPK:SOLTF) » Definitions » Shiller PE Ratio

SOLTF (Nxera Pharma Co) Shiller PE Ratio : (As of Dec. 16, 2024)


View and export this data going back to . Start your Free Trial

What is Nxera Pharma Co Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Nxera Pharma Co Shiller PE Ratio Historical Data

The historical data trend for Nxera Pharma Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nxera Pharma Co Shiller PE Ratio Chart

Nxera Pharma Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 509.87 204.11 180.19 -

Nxera Pharma Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Nxera Pharma Co's Shiller PE Ratio

For the Biotechnology subindustry, Nxera Pharma Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nxera Pharma Co's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nxera Pharma Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Nxera Pharma Co's Shiller PE Ratio falls into.



Nxera Pharma Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Nxera Pharma Co's E10 for the quarter that ended in Jun. 2024 is calculated as:

For example, Nxera Pharma Co's adjusted earnings per share data for the three months ended in Jun. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=-0.1/108.2000*108.2000
=-0.100

Current CPI (Jun. 2024) = 108.2000.

Nxera Pharma Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201409 0.022 98.500 0.024
201412 0.035 97.900 0.039
201503 0.038 97.900 0.042
201506 -0.140 98.400 -0.154
201509 -0.025 98.500 -0.027
201512 0.409 98.100 0.451
201603 -0.532 97.900 -0.588
201606 1.561 98.100 1.722
201609 -0.063 98.000 -0.070
201612 0.007 98.400 0.008
201703 -0.118 98.100 -0.130
201706 0.039 98.500 0.043
201709 -0.129 98.800 -0.141
201712 -0.151 99.400 -0.164
201803 -0.120 99.200 -0.131
201806 -0.187 99.200 -0.204
201809 -0.242 99.900 -0.262
201812 -0.310 99.700 -0.336
201903 0.120 99.700 0.130
201906 -0.075 99.800 -0.081
201909 0.127 100.100 0.137
201912 -0.004 100.500 -0.004
202003 -0.090 100.300 -0.097
202006 -0.165 99.900 -0.179
202009 0.056 99.900 0.061
202012 0.382 99.300 0.416
202103 -0.131 99.900 -0.142
202106 -0.128 99.500 -0.139
202109 0.052 100.100 0.056
202112 0.307 100.100 0.332
202203 -0.214 101.100 -0.229
202206 -0.134 101.800 -0.142
202209 0.026 103.100 0.027
202212 0.327 104.100 0.340
202303 -0.128 104.400 -0.133
202306 -0.057 105.200 -0.059
202309 -0.405 106.200 -0.413
202312 -0.015 106.800 -0.015
202403 -0.245 107.200 -0.247
202406 -0.100 108.200 -0.100

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Nxera Pharma Co  (OTCPK:SOLTF) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Nxera Pharma Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Nxera Pharma Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Nxera Pharma Co Business Description

Traded in Other Exchanges
Address
Midtown East, 9-7-2 Akasaka Minato-ku, Tokyo, JPN, 107-0052
Nxera Pharma Co Ltd is a science and technology-led biopharmaceutical company. Its activities are drug discovery, drug development and the commercialization of pharmaceutical products. The focus is to discover new medicines for unmet medical needs, including novel small molecules, peptides and therapeutic antibodies targeting G Protein Coupled Receptors (GPCRs).